An Inhibited Dopamine Synthesizing Cell Model of AADC Deficiency
Life Sciences, Medicine and Biomedicine · 2019
DOI: 10.28916/lsmb.3.6.2019.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, Medicine and Biomedicine, 2019. Verfasst von Melati Khalid und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Introduction
Aromatic L-amino acid decarboxylase deficiency (AADC) is a rare autosomal recessive pediatric neurotransmitter disease. To date it remains poorly understood mainly due to an absence of a disease model. The dopaminergic neuroblastoma cell SH-SY5Y was chosen to develop our AADC deficiency model. These cells are not native dopamine synthesizers.
Objective
To develop a dopamine-producing cellular model of AADC deficiency using SH-SY5Y neuroblastoma cells.
Methods
Dopamine pathway proteins were identified with Western Blotting. Dopaminergic differentiation was attempted using all-trans retinoic acid (ATRA) with dopamine detection via HPLC-ECD post alumina extraction. Treatment with L-DOPA provided SH-SY5Y with excess precursor. RT-PCR was used to determine the expression of markers of mature neurons.
Results
Western Blot screening identified AADC, dopamine β-hydroxylase and tyrosine hyrdoxylase proteins, indicative of a dopaminergic pathway. ATRA was unsuccessful in producing dopamine from the cells. L-DOPA treatment however, generated dopamine first visible as a HPLC-ECD peak 30 minutes post-incubation. Prior to this, SH-SY5Y dopamine synthesis from L-DOPA has never been documented. This de novo synthesis is then inhibited using benserazide to form our AADC deficiency cell model. RT-PCR showed that SH-SY5Y cells express markers of mature neurons in its ‘native’ state and is not affected by L-DOPA and benserazide treatment. This cell model will potentially benefit many areas of AADC deficiency research.
Conclusion
SH-SY5Y cells produced HPLC-ECD measureable amounts of dopamine with the addition of L-DOPA. Our model of AADC deficiency is generated by quelling the dopamine production with Benserazide.
Zitieren
APA
Khalid, M., & Moklas, M. A. M. (2019). An Inhibited Dopamine Synthesizing Cell Model of AADC Deficiency. Life Sciences, Medicine and Biomedicine. https://doi.org/10.28916/lsmb.3.6.2019.24
Vancouver
Khalid M, Moklas MAM. An Inhibited Dopamine Synthesizing Cell Model of AADC Deficiency. Life Sciences, Medicine and Biomedicine. 2019. doi:10.28916/lsmb.3.6.2019.24
BibTeX
@article{Khalid2019,
author = {Khalid, Melati and Moklas, Mohamad Aris Mohd},
title = {An Inhibited Dopamine Synthesizing Cell Model of AADC Deficiency},
journal = {Life Sciences, Medicine and Biomedicine},
year = {2019},
doi = {10.28916/lsmb.3.6.2019.24}
}
EUVIMED